Report cover image

Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Sep 18, 2024
Length 126 Pages
SKU # PROD19315655

Description

Cancer Diagnostics Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global cancer diagnostics market is expected to grow at a CAGR of around 8.1% during 2025-2034. This report on global cancer diagnostics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global cancer diagnostics market by segmenting the market based on product, technology, type, application, end user, and region. Also, detailed profiles of companies operating in the cancer diagnostics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

● Rising Prevalence of Cancer
● The Increase in Adoption of Latest Technologies

Market Challenges

● High Cost
● Inadequate Reimbursement Policies

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product

● Consumables
Antibodies
Kits and Reagents
Probes
Others
● Instruments
Pathology-based Instruments
Imaging Instruments
Biopsy Instruments

Market by Technology

● IVD Testing
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Others
● Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Mammography
Ultrasound
● Biopsy Technique

Market by Type

● Biopsy
● Endoscopy
● Imaging
● Genetic Tests
● Laboratory Tests
● Others

Market by Application

● Breast Cancer
● Lung Cancer
● Cervical Cancer
● Kidney Cancer
● Liver Cancer
● Pancreatic Cancer
● Ovarian Cancer
● Other Applications

Market by End User

● Hospitals and Clinics
● Diagnostic Laboratories
● Others

Market by Region

● Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
● North America
United States
Canada
● Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
● Latin America
Mexico
Brazil
Argentina
Rest of Latin America
● Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

126 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Cancer Diagnostics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Cancer Diagnostics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Cancer Diagnostics Market by Product
5.1. Introduction
5.2. Consumables
5.2.1. Antibodies
5.2.2. Kits and Reagents
5.2.3. Probes
5.2.4. Others
5.3. Instruments
5.3.1. Pathology-based Instruments
5.3.2. Imaging Instruments
5.3.3. Biopsy Instruments
6. Global Cancer Diagnostics Market by Technology
6.1. Introduction
6.2. IVD Testing
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. In Situ Hybridization (ISH)
6.2.3. Immunohistochemistry (IHC)
6.2.4. Next-generation Sequencing (NGS)
6.2.5. Microarrays
6.2.6. Flow Cytometry
6.2.7. Immunoassays
6.2.8. Others
6.3. Imaging
6.3.1. Magnetic Resonance Imaging (MRI)
6.3.2. Computed Tomography (CT)
6.3.3. Positron Emission Tomography (PET)
6.3.4. Mammography
6.3.5. Ultrasound
6.4. Biopsy Technique
7. Global Cancer Diagnostics Market by Type
7.1. Introduction
7.2. Biopsy
7.3. Endoscopy
7.4. Imaging
7.5. Genetic Tests
7.6. Laboratory Tests
7.7. Others
8. Global Cancer Diagnostic Market by Application
8.1. Introduction
8.2. Breast Cancer
8.3. Lung Cancer
8.4. Cervical Cancer
8.5. Kidney Cancer
8.6. Liver Cancer
8.7. Pancreatic Cancer
8.8. Ovarian Cancer
8.9. Other
9. Global Cancer Diagnostics Market by End User
9.1. Introduction
9.2. Hospitals and Clinics
9.3. Diagnostic Laboratories
9.4. Others
10. Global Cancer Diagnostics Market by Region
10.1. Introduction
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Netherlands
10.2.8. Rest of the Europe
10.3. North America
10.3.1. United States
10.3.2. Canada
10.4. Asia Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Indonesia
10.4.7. Rest of the Asia Pacific
10.5. Latin America
10.5.1. Mexico
10.5.2. Brazil
10.5.3. Argentina
10.5.4. Rest of Latin America
10.6. Middle East & Africa
10.6.1. Saudi Arabia
10.6.2. Turkey
10.6.3. Iran
10.6.4. United Arab Emirates
10.6.5. Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Company Profiles
14.1.1 Abbott Laboratories
14.1.2 Agilent Technologies
14.1.3 Becton, Dickinson and Company
14.1.4 Biomeriuex SA
14.1.5 Bio-Rad Laboratories, Inc.
14.1.6 Danaher Corporation (GE Healthcare)
14.1.7 GE Healthcare
14.1.8 Hologic, Inc.
14.1.9 Koninklijke Philips N.V. (Philips Healthcare)
14.1.10 Myriad Genetics Laboratories
14.1.11 Qiagen N.V.
14.1.12 Roche Holdings AG (F. Hoffmann-La Roche Ltd.)
14.1.13 Siemens Healthcare GmbH
14.1.14 Thermo Fisher Scientific Inc.
List of Figures
Figure 1: Global Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 2: Global Cancer Diagnostics Market by Product, 2024
Figure 3: Global Cancer Diagnostics Market by Technology, 2024
Figure 4: Global Cancer Diagnostics Market by Type, 2024
Figure 5: Global Cancer Diagnostics Market by Application, 2024
Figure 6: Global Cancer Diagnostics Market by End User, 2024
Figure 7: Global Cancer Diagnostics Market by Region, 2024
Figure 8: Global Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 9: Global Cancer Diagnostics Market by Product (in %), 2024 & 2034
Figure 10: Global Consumables Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 11: Global Consumables Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 12: Antibodies Consumables Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 13: Kits and Reagents Consumables Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 14: Probes Consumables Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 15: Other Products Consumables Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 16: Global Instruments Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 17: Global Instruments Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 18: Pathology-based Instruments Instruments Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 19: Imaging Instruments Instruments Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 20: Biopsy Instruments Instruments Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 21: Global Cancer Diagnostics Market by Technology (in %), 2024 & 2034
Figure 22: Global IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 23: Global IVD Testing Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 24: Polymerase Chain Reaction (PCR) IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 25: In Situ Hybridization (ISH) IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 26: Immunohistochemistry (IHC) IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 27: Next-generation Sequencing (NGS) IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 28: Microarrays IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 29: Flow Cytometry IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 30: Immunoassays IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 31: Other Products IVD Testing Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 32: Global Imaging Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 33: Global Imaging Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 34: Magnetic Resonance Imaging (MRI) Imaging Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 35: Computed Tomography (CT) Imaging Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 36: Positron Emission Tomography (PET) Imaging Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 37: Mammography Imaging Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 38: Ultrasound Imaging Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 39: Global Biopsy Technique Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 40: Global Biopsy Technique Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 41: Global Cancer Diagnostics Market by Type (in %), 2024 & 2034
Figure 42: Global Biopsy Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 43: Global Biopsy Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 44: Global Endoscopy Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 45: Global Endoscopy Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 46: Global Imaging Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 47: Global Imaging Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 48: Global Genetic Tests Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 49: Global Genetic Tests Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 50: Global Laboratory Tests Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 51: Global Laboratory Tests Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 52: Global Other Types Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 53: Global Other Types Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 54: Global Cancer Diagnostics Market by Application (in %), 2024 & 2034
Figure 55: Global Breast Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 56: Global Breast Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 57: Global Lung Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 58: Global Lung Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 59: Global Cervical Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 60: Global Cervical Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 61: Global Kidney Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 62: Global Kidney Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 63: Global Liver Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 64: Global Liver Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 65: Global Pancreatic Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 66: Global Pancreatic Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 67: Global Ovarian Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 68: Global Ovarian Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 69: Global Other Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 70: Global Other Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 71: Global Cancer Diagnostics Market by End User (in %), 2024 & 2034
Figure 72: Global Hospitals and Clinics Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 73: Global Hospitals and Clinics Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 74: Global Diagnostic Laboratories Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 75: Global Diagnostic Laboratories Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 76: Global Other End Users Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 77: Global Other End Users Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 78: Global Cancer Diagnostics Market by Region (in %), 2024 & 2034
Figure 79: Europe Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 80: Europe Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 81: Europe Cancer Diagnostics Market by Country (in %), 2024 & 2034
Figure 82: Germany Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 83: United Kingdom Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 84: France Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 85: Italy Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 86: Spain Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 87: Russia Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 88: Netherlands Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 89: North America Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 90: North America Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 91: North America Cancer Diagnostics Market by Country (in %), 2024 & 2034
Figure 92: United States Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 93: Canada Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 94: Asia Pacific Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 95: Asia Pacific Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 96: Asia Pacific Cancer Diagnostics Market by Country (in %), 2024 & 2034
Figure 97: China Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 98: Japan Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 99: India Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 100: South Korea Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 101: Australia Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 102: Indonesia Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 103: Latin America Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 104: Latin America Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 105: Latin America Cancer Diagnostics Market by Country (in %), 2024 & 2034
Figure 106: Mexico Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 107: Brazil Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 108: Argentina Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 109: Middle East & Africa Cancer Diagnostics Market (in US$ Million), 2020-2024
Figure 110: Middle East & Africa Cancer Diagnostics Market (in US$ Million), 2025-2034
Figure 111: Middle East & Africa Cancer Diagnostics Market by Country (in %), 2024 & 2034
Figure 112: Saudi Arabia Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 113: Turkey Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 114: Iran Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 115: UAE Cancer Diagnostics Market (in US$ Million), 2020-2034
Figure 116: Market Value Chain
List of Tables
Table 1: Global Cancer Diagnostics Market Portraiture
Table 2: Global Cancer Diagnostics Market by Product (in US$ Million), 2024 & 2034
Table 3: Global Cancer Diagnostics Market by Technology (in US$ Million), 2024 & 2034
Table 4: Global Cancer Diagnostics Market by Type (in US$ Million), 2024 & 2034
Table 5: Global Cancer Diagnostics Market by End User (in US$ Million), 2024 & 2034
Table 6: Global Cancer Diagnostics Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Cancer Diagnostics Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Cancer Diagnostics Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Cancer Diagnostics Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Cancer Diagnostics Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Cancer Diagnostics Market by Country (in US$ Million),
2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us